Dapiprazole
As of the edition of 20 October 2026, Dapiprazole is a small molecule: marketed, first approved in 1990 (US); acts on ADRA1A; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1990
- Kind
- Small molecule
- First approved
- 31 December 1990 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Fera Pharmaceuticals
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| ADRA1A | Alpha-1A adrenergic receptor | P35348 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Fera Pharmaceuticals | Acquired holder | 2011 to now |
| Angelini Pharma | Originator | 1990 to 2011 |